Endpoint definition
↥
FinnGen phenotype data
Filter registries None
Check pre-conditions None
Check conditions None
Apply sex-specific rule None
COPD_CVDMETABOCOMORB
Extra metadata
First used in FinnGen datafreeze
DF2
COPD_CVDMETABOCOMORB
Similar endpoints
↥List of similar endpoints to
COPD Co-morbidites, CVD and metabolic diseases
based on the number of shared cases.
Broader endpoints:
- ILD Co-morbidites, CVD and metabolic diseases
- Multimorbidity, for COPD
- ILD-related co-morbidities
- COPD-associated co-morbidities
- Co-morbidities of interest (NEURO)
Narrower endpoints:
Summary Statistics
↥Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 96453 | 44250 | 52203 |
| Unadjusted prevalence (%) | 37.09 | 30.11 | 46.16 |
| Mean age at first event (years) | 56.34 | 55.68 | 56.91 |
Mortality
| Follow-up | Absolute risk | HR [95% CI] | p | N |
|---|---|---|---|---|
| 1998–2019 | 0.05 | 5.26 [4.91, 5.63] | <1e-100 | 16523 |
| 15 years | 0.03 | 6.52 [6.10, 6.96] | <1e-100 | 13615 |
| 5 years | 0.01 | 10.42 [9.52, 11.40] | <1e-100 | 5935 |
| 1 year | 0.00 | 24.00 [20.16, 28.58] | <1e-100 | 2671 |
Correlations
↥
Index endpoint: COPD_CVDMETABOCOMORB – COPD Co-morbidites, CVD and metabolic diseases
GWS hits:
Survival analyses between endpoints
↥Plot
before COPD Co-morbidites, CVD and metabolic diseases
after COPD Co-morbidites, CVD and metabolic diseases
Loading survival analyses plot
Table
Loading survival analyses table